California Public Employees Retirement System Sells 9,207 Shares of HealthEquity, Inc. (NASDAQ:HQY)

California Public Employees Retirement System lessened its stake in HealthEquity, Inc. (NASDAQ:HQYGet Rating) by 5.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 154,905 shares of the company’s stock after selling 9,207 shares during the period. California Public Employees Retirement System owned about 0.18% of HealthEquity worth $9,510,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the stock. Assetmark Inc. raised its position in HealthEquity by 387.1% in the second quarter. Assetmark Inc. now owns 755 shares of the company’s stock worth $46,000 after purchasing an additional 600 shares in the last quarter. Signaturefd LLC raised its position in HealthEquity by 44.3% in the first quarter. Signaturefd LLC now owns 954 shares of the company’s stock worth $64,000 after purchasing an additional 293 shares in the last quarter. Clearstead Advisors LLC acquired a new position in HealthEquity in the first quarter worth about $65,000. First Horizon Advisors Inc. raised its position in HealthEquity by 701.3% in the second quarter. First Horizon Advisors Inc. now owns 1,202 shares of the company’s stock worth $73,000 after purchasing an additional 1,052 shares in the last quarter. Finally, Captrust Financial Advisors raised its position in HealthEquity by 92.5% in the first quarter. Captrust Financial Advisors now owns 1,176 shares of the company’s stock worth $79,000 after purchasing an additional 565 shares in the last quarter. Institutional investors own 99.43% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on HQY shares. Wells Fargo & Company increased their price target on shares of HealthEquity from $100.00 to $104.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 25th. Robert W. Baird raised their price objective on shares of HealthEquity from $47.00 to $67.00 and gave the stock a “neutral” rating in a report on Wednesday, September 7th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of HealthEquity from $67.00 to $68.00 and gave the stock a “buy” rating in a report on Thursday, September 8th. KeyCorp assumed coverage on shares of HealthEquity in a report on Thursday, September 15th. They set an “overweight” rating and a $85.00 price objective for the company. Finally, Raymond James raised their price objective on shares of HealthEquity from $70.00 to $75.00 and gave the stock an “outperform” rating in a report on Monday, September 12th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat.com, HealthEquity presently has a consensus rating of “Moderate Buy” and an average price target of $77.64.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Debra Charlotte Mccowan sold 4,225 shares of the firm’s stock in a transaction that occurred on Tuesday, September 27th. The shares were sold at an average price of $70.91, for a total value of $299,594.75. Following the transaction, the director now directly owns 7,072 shares of the company’s stock, valued at $501,475.52. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, EVP Delano Ladd sold 5,897 shares of HealthEquity stock in a transaction on Friday, October 21st. The shares were sold at an average price of $75.00, for a total transaction of $442,275.00. Following the transaction, the executive vice president now directly owns 37,471 shares of the company’s stock, valued at $2,810,325. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Debra Charlotte Mccowan sold 4,225 shares of HealthEquity stock in a transaction on Tuesday, September 27th. The stock was sold at an average price of $70.91, for a total transaction of $299,594.75. Following the transaction, the director now directly owns 7,072 shares in the company, valued at $501,475.52. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 46,648 shares of company stock valued at $3,355,690. 2.80% of the stock is currently owned by insiders.

HealthEquity Stock Performance

Shares of HQY stock opened at $63.82 on Wednesday. HealthEquity, Inc. has a 52-week low of $36.81 and a 52-week high of $79.20. The stock has a market cap of $5.39 billion, a PE ratio of -86.24, a PEG ratio of 3.34 and a beta of 0.87. The firm’s 50 day moving average price is $70.53 and its two-hundred day moving average price is $64.92.

HealthEquity (NASDAQ:HQYGet Rating) last announced its quarterly earnings data on Tuesday, September 6th. The company reported $0.16 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.01). HealthEquity had a negative net margin of 7.82% and a positive return on equity of 2.86%. The business had revenue of $206.14 million during the quarter, compared to the consensus estimate of $203.40 million. During the same period in the previous year, the business posted $0.21 earnings per share. As a group, sell-side analysts predict that HealthEquity, Inc. will post 0.69 earnings per share for the current fiscal year.

HealthEquity Profile

(Get Rating)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Stories

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYGet Rating).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.